![Maged Shenouda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maged Shenouda
Finansdirektör/CFO på
RELMADA THERAPEUTICS, INC.
Förmögenhet: 6 M $ per 2026-06-30
Profil
Maged S.
Shenouda is Chief Financial Officer at Relmada Therapeutics, Inc. since 2020, with employment at the firm starting in 2015.
Former positions include Director at Protea Biosciences, Inc. and Protea Biosciences Group, Inc. from 2015 to 2017; Managing Director at Stifel, Nicolaus & Co., Inc. from 2010 to 2011; Managing Director at Blueprint Life Science Group from 2012 to 2013; Senior VP, Head-Business Development & Licensing at Travere Therapeutics, Inc. in 2014; Chief Financial & Accounting Officer at GridAI Technologies Corp.
in 2019; Principal at Abbott Laboratories; Analyst at Bear, Stearns & Co., Inc. in 1999; Analyst at UBS Securities LLC from 2004 to 2010; Analyst at JPMorgan Securities LLC in 2003; Management Consultant at Pricewaterhouse & Co.; Analyst at Salomon Smith Barney.
Education includes undergraduate studies at St. John's University and an MBA from Rutgers Business School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
RELMADA THERAPEUTICS INC 0,76 % | 2026-03-26 | 800 000 ( 0,76 % ) | 6 M $ | 2026-06-30 |
Aktiva positioner av Maged Shenouda
| Företag | Position | Start |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Finansdirektör/CFO | 2020-01-09 |
Tidigare kända positioner av Maged Shenouda
| Företag | Position | Slut |
|---|---|---|
| GRIDAI TECHNOLOGIES CORP. | Finansdirektör/CFO | 2019-12-01 |
| PROTEA BIOSCIENCES GROUP, INC | Direktör/Styrelseledamot | 2017-06-09 |
| TRAVERE THERAPEUTICS, INC. | Företagsledare/Principal | 2014-11-01 |
Blueprint Life Science Group
 Blueprint Life Science Group Miscellaneous Commercial ServicesCommercial Services Blueprint Life Science Group is a healthcare-dedicated corporate advisory and investor relations firm. The company offers a full suite of investor relations and proprietary strategic advisory services to their clients. Founded in 2006, the company works behind the scenes and at the forefront of daily IR operations to enhance management's ability to make strategic decisions and produce results. The company has a diversified team with backgrounds in portfolio management, sellside research, equity capital markets, design and media, and investor communications. Blueprint's investor relations platform is designed to bolster clients' overall presence in the life science community while providing a robust flow of information and ideas. The firm also has a seasoned Board of Advisors that assists in validating strategies and facilitating outcomes while serving as an additional resource for clients. The company is based in San Francisco, CA. | Företagsledare/Principal | 2013-09-01 |
Stifel, Nicolaus & Co., Inc.
 Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2011-01-01 |
Maged Shenoudas utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
98
Första gradens relationer
15
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 15 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Bear, Stearns & Co., Inc.
 Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Provides investment banking, securities trading and brokerage Services | Finance |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Protea Biosciences, Inc.
 Protea Biosciences, Inc. Medical SpecialtiesHealth Technology Develops technology for micro fluidic protein separation and detection | Health Technology |
Stifel, Nicolaus & Co., Inc.
Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Pricewaterhouse & Co.
 Pricewaterhouse & Co. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
St. John's University
 St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Salomon Smith Barney
 Salomon Smith Barney Investment Banks/BrokersFinance Provides brokerage services | Finance |
Protea Biosciences Group, Inc.
 Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides innovative bioanalytical solutions | Commercial Services |
Blueprint Life Science Group
Blueprint Life Science Group Miscellaneous Commercial ServicesCommercial Services Blueprint Life Science Group is a healthcare-dedicated corporate advisory and investor relations firm. The company offers a full suite of investor relations and proprietary strategic advisory services to their clients. Founded in 2006, the company works behind the scenes and at the forefront of daily IR operations to enhance management's ability to make strategic decisions and produce results. The company has a diversified team with backgrounds in portfolio management, sellside research, equity capital markets, design and media, and investor communications. Blueprint's investor relations platform is designed to bolster clients' overall presence in the life science community while providing a robust flow of information and ideas. The firm also has a seasoned Board of Advisors that assists in validating strategies and facilitating outcomes while serving as an additional resource for clients. The company is based in San Francisco, CA. | Commercial Services |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entero Therapeutics, Inc.
 Entero Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures non-systemic therapies for the treatment of patients with gastrointestinal diseases | Health Technology |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
